|AAPS Pharmaceutical Career News|
|Jun. 13, 2014|
Less Than a Week Away! The 1st AAPS Virtual Career Fair Is June 18!
Meet employers who are looking for candidates just like you at the AAPS one-of-a-kind Virtual Career Fair!
What: AAPS Virtual Career Fair
When: Wednesday, June 18 from noon to 2 p.m.
Cost: Free to all candidates
Who: Participating employers currently include: ABC Laboratories, Actavis Inc, Celgene, GlaxoSmithKline, and Regeneron Pharmaceuticals
For more information, please go to our Virtual Career Fair webpage. If you have any questions, please contact Kevin Folk, Career Services Specialist, at +1.703.248.4721 or email FolkK@aaps.org.More
eCourses for Personal Growth and Career Development
It’s no secret that elearning has opened up an abundance of opportunities for individuals of all backgrounds to expand their knowledge and skill sets, right from their computer. Whether at work or home, students and professionals can participate in these online classes, seminars, and courses when they desire and at their own pace.
You’ve likely heard these and other benefits of elearning touted. But what do these benefits mean to you? How have they helped grow and enhance knowledge and careers? Three American Association of Pharmaceutical Scientists (AAPS) members recently relayed their experiences with the AAPS Biotechnology 101 ecourse.
To read more on expanding your skills, please refer to our new Career Success section of the AAPS Career Center.More
NIH Report Warns of Looming Physician-Scientist Shortage
Recently the mainstream has come to embrace the fact that the job market for Ph.D. biomedical researchers is overcrowded. According to a new report from a working group of the National Institutes of Health (NIH) Advisory Committee to the Director (ACD), the job market looks very different for physician-scientists. In fact, “[t]here may not be enough [physician-scientists] to replace those preparing to retire,” Jocelyn Kaiser reports in a ScienceInsider.More
How Leaders Win With Strategic Innovation
By Scott Steinberg
As modern leaders are aware, risk and uncertainty are on the rise today, and making mistakes is currently the No. 1 fear in the workplace. But if your organization wants to continually change, adapt and reinvent itself to strategically innovate and evolve in tune with changing times, it's worth noting that we must become comfortable with all of these factors and constantly seek ways to mitigate them.More
Life Sciences Week Highlights Health Of Industry In The State
The Christie administration and the bio tech industry are celebrating Life Sciences Week in an effort to show the industry — once one of the biggest and most important in New Jersey — is still very much alive. Department of Labor and Workforce Development Commissioner Harold J. Wirths said recent layoffs have led to a growing misconception about the status of the industry.More
Career Advice From Katie Couric
Business News Daily
Katie Couric is one of the world's most well-known television journalists and talk show hosts, not to mention a New York Times best-selling author. With a career that spans all three major news networks – NBC, ABC and CBS – and having made history as the first woman to anchor a weekday evening news program by herself, Couric knows a thing or two about being successful.More
Big Pharma Looks For New Models
In a position statement on the current state of the pharmaceutical industry, the Royal Society of Chemistry (RSC) points out that there is a growing feeling around the world that the "big" pharma model is broken. The sheer scale of the costs involved in the search for new products has reached the point where even a few failures could bring a big pharma to its knees.More
Italy's Move To Fund Unapproved Use of Roche's Avastin Alarms the Industry
In the U.S. pushing drugs for unapproved uses has gotten companies into big trouble. In Italy, the opposite is now true. To save money, the government will pay for patients to be treated for an eye disease with Roche's Avastin, a drug not approved for that use, and has taken legal action against the Swiss drugmaker and marketing partner Novartis for steering physicians toward the pricier Lucentis, which is. Italy's approach, which may look appealing to other cash-strapped European countries, drew a sharp rebuke from both companies as well as Big Pharma in general.More
Prospects For Job Mobility, Advice For Your Mid-Career Reinvention
Southern California Public Radio
The current steady job growth - albeit with caveats - and stability of the unemployment rate should spark labor mobility for American workers. Recently, AirTalk looked at how specific industries are faring since the Great Recession. Numbers from the Labor Department (jazzed up by The New York Times) break down which sectors workers would be wise to pursue, including wage expectations.More
Tech, Healthcare and Pharma Offer Hot Jobs To B-schoolers
The Hindu Business Line
Business school graduates are more likely to do well if they look beyond the traditional sectors such as finance, products & services and consulting to fields including technology, manufacturing and healthcare, according to a survey conducted by the Graduate Management Admission Council (GMAC).More
Vietnam's Pharmaceutical Market Set for Healthy Growth
The next six years look to be very interesting for the pharmaceutical industry in Vietnam. Recent economic forecasts have predicted a $5 billion increase in value over the next six years, reaching a net worth of $8 billion by 2020 – a compound annual growth rate of 15.4 percent. Driving this market growth is the Vietnamese government’s goal of achieving universal health coverage by 2015. Thirty percent of the country’s population still have no form of public health insurance. Additionally, private health expenditures remain high at 57 percent of the country’s total health spending.More
Sheridan Post-Grad Course Trains Future Pharma Employees
Sheridan College has announced a new partnership with Patheon Inc., a world-leading pharmaceutical company with locations in Mississauga and Whitby. Patheon has joined Sheridan’s efforts to create an Industrial Pharmacy Technologist postgraduate certificate to be offered by the Faculty of Applied Health and Community Studies.More
Drugmaker Remedy for Scandal Is More Chinese for China
Drugmakers are putting more Chinese nationals in important positions in the country to avoid the kind of bribery scandal plaguing GlaxoSmithKline Plc, according to the head of Europe’s pharmaceutical industry group. Chinese police handed a case against Glaxo’s China unit to prosecutors last month, alleging that Mark Reilly, a British national who previously led the group, helped set up and expand sales departments that offered bribes to doctors in return for prescribing drugs. The London-based company also faces a U.K. criminal probe.More